SEC Form D · filed January 6, 2021
EyePoint Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
George O. Elston · Watertown, MAExecGoran Ando · Reading, United KingdomDirectorScott Jones · Houston, TXExecStefan K. Schauss · VANCOUVER, British Columbia, CanadaExec · DirectorJohn R. Landis, Ph.D., M.S · Watertown, MADirectorKirsten Green · San Francisco, CADirectorWendy O. Dicicco · Watertown, MADirectorRonald W. Eastman · Watertown, MADirectorDavid R. Guyer, M.D · Watertown, MADirectorJason R. Roswig · New York, NYDirectorSachin C. Bavishi · New York, NYDirectorDario Paggiarino, M.D · WATERTOWN, MAExecGeorge O. Elston · Watertown, MAExecHalle Capital Partners GP LLC · New York, NYDirectorScott Jones · Fort Worth, TXExecYe R. Liu · Watertown, MADirectorJohn R. Landis, Ph.D., M.S · Watertown, MADirectorMichael Puopolo · New York, NYExec · DirectorYe R. Liu · Watertown, MADirectorDouglas W. Godshall · Watertown, MADirectorGoran Ando · WATERTOWN, MADirectorWendy O. Dicicco · Watertown, MADirectorDario Paggiarino, M.D · WATERTOWN, MAExecNancy Lurker · WATERTOWN, MAExec · DirectorDavid R. Guyer, M.D · Watertown, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗